Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose for multiple sulfatase deficiency (MSD)
IRCT20130829014521N17Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, single-arm trial of trehalose in multiple sulfatase deficiency (MSD), sponsored by Mashhad University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
trehalose
03
Conditions
multiple sulfatase deficiency (MSD)
Beyond the preview
Go deeper on IRCT20130829014521N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130829014521N17.